Chemical Inhibitors and microRNAs (miRNA) Targeting the Mammalian Target of Rapamycin (mTOR) Pathway: Potential for Novel Anticancer Therapeutics

By AlQurashi Naif   Hashimi Saeed M.   Wei Ming Q.  

International Journal of Molecular Sciences, Vol. 14, Iss. 2, 2013-02 ,pp. : 3874-3900

MDPI

Access to resources Recommend Favorite

Targeting the Mammalian Target of Rapamycin (mTOR) in Cancer Therapy: Lessons from Past and Future Perspectives

By Dufour Marc   Dormond-Meuwly Anne   Demartines Nicolas   Dormond Olivier  

Cancers, Vol. 3, Iss. 2, 2011-05 ,pp. : 2478-2500

MDPI

Access to resources Recommend Favorite

Role of mTOR Inhibitors in Kidney Disease

By Kajiwara Moto   Masuda Satohiro  

International Journal of Molecular Sciences, Vol. 17, Iss. 6, 2016-06 ,pp. : 975-975

MDPI

Access to resources Recommend Favorite

Crosstalk between Edc4 and Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling in mRNA Decapping

By Rahman Hazir   Qasim Muhammad   Oellerich Michael   Asif Abdul R.  

International Journal of Molecular Sciences, Vol. 15, Iss. 12, 2014-12 ,pp. : 23179-23195

MDPI

Access to resources Recommend Favorite

Current Models of Mammalian Target of Rapamycin Complex 1 (mTORC1) Activation by Growth Factors and Amino Acids

By Zheng Xu   Liang Yan   He Qiburi   Yao Ruiyuan   Bao Wenlei   Bao Lili   Wang Yanfeng   Wang Zhigang  

International Journal of Molecular Sciences, Vol. 15, Iss. 11, 2014-11 ,pp. : 20753-20769

MDPI

Access to resources Recommend Favorite